BRETT SCHEIDEMANTEL: Open Payments
NPI 1952072688 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,181 in 35 payments from 19 companies in 2025. Trend: 2023 $1,149 · 2024 $886 · 2025 $1,181
Food & beverage: $1,181
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $264 |
| COLOPLAST CORP | 1 | $153 |
| Sumitomo Pharma America, Inc. | 5 | $112 |
| Procept Biorobotics Corporation | 1 | $97 |
| Dendreon Pharmaceuticals LLC | 3 | $87 |
| UROGEN PHARMA, INC. | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Endo USA, Inc. | 3 | $61 |
| TOLMAR, INC. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
Products named: Titan, ERLEADA, ORGOVYX, AQUABEAM ROBOTIC SYSTEM, PROVENGE, PLUVICTO, XIAFLEX, JATENZO.
Industry payments across MI — which companies pay providers there.
